Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Flavian Ştefan Rădulescu"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Dalia Simona Miron, Victor Voicu, Adrian C. Nicolescu, Mihaela Ionescu, Flavian Ştefan Rădulescu, Constantin Mircioiu
Publikováno v:
Toxicology Letters. 219:99-106
Chemical warfare agents, such as soman, and pesticides, such as chlorpyrifos, dichlorvos or malathion, are toxic organophosphorous compounds (OPCs) that are readily absorbed by the skin. Decontamination using solvents or surfactants may modify the co
Publikováno v:
International journal of pharmaceutics. 509(1-2)
Both biopharmaceutics classification system (BCS) and topical drug classification system (TCS) are based on sound scientific principles with the aim of providing biowaiver and reducing regulatory burden without lowering the quality requirements and s
Publikováno v:
European Neuropsychopharmacology. 22:319-329
The metabolic processes frequently trigger highly complex pharmacokinetic (PK) and pharmacodynamic (PD) characteristics for the coexisting entities, parent drug and its active or inactive metabolites. The interpretation of both individual and cumulat
Publikováno v:
Journal of Applied Toxicology. 30:719-729
Undoubtedly, the use of oximes represents real progress in counteracting intoxications with organophosphates (OP), through potentiating antidotal effects of atropine. The penetration extent of these compounds through the blood-brain barrier (BBB) to
Publikováno v:
Acta Endocrinologica (Bucharest). 6:265-285
The pharmacokinetic characteristics of a compound as well as the immediate consequences of its physicochemical behavior during interactions with biological structures, represent the key issues for its pharmacodynamic profile, starting from the most f
Publikováno v:
International journal of pharmaceutics. 491(1-2)
The Biopharmaceutics Classification System (BCS) for oral immediate release solid drug products has been very successful; its implementation in drug industry and regulatory approval has shown significant progress. This has been the case primarily bec
Publikováno v:
Expert opinion on drug metabolismtoxicology. 11(1)
The therapeutic outcome of oximes used as reactivators of phosphorylated human acetylcholinesterase (AChE) is influenced, among other factors, by their biological distribution, their in vivo ability to achieve the nucleophilic attack and their affini
Publikováno v:
Pharmaceutical development and technology. 19(2)
Two 1% and one 0.75% metronidazole cream products were approved as bioequivalent products. These products were evaluated for their in vivo cutaneous penetration characteristics by dermatopharmacokinetic (DPK) and dermal microdialysis (DMD) sampling m
Publikováno v:
Expert opinion on drug metabolismtoxicology. 9(1)
The more or less systematic studies on the specific activity of oximes as reactivators of acetylcholinesterase (AChE) inhibited by organophosphorus (OP) compounds provide a panoramic image of their pharmacological and toxicological profiles. Establis